Trademark: SLTX
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
Proof of use for SLTX
We do not have any records of a proof of use for SLTX at this moment.
Possible trademark infringements of SLTX
Basic Information about SLTX
- Serial Number
- 88197578
- Filing Date
- 16 Nov 2018
- Registration Number
- 6201037
- Registration Date
- 17 Nov 2020
- Mark Drawing Code
- 4
Classifications
Declare the trademark use of SLTX on the blockchain with WikiTrademarks.io.
- First use of SLTX anywhere
- SLTX was first used on 17 Sep 2020 for the primary classification of goods and services, international, 001 (Chemicals)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 001
- US Codes
- 001; 005; 006; 010; 026; 046
- First use of SLTX anywhere
- SLTX was first used on 28 Jul 2020 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 006; 018; 044; 046; 051; 052
Who owns SLTX?
1. Sigilon Therapeutics, Inc. Cambridge MA
2. Sigilon Therapeutics, Inc. Cambridge MA
3. Sigilon Therapeutics, Inc. Cambridge MA
Correspondent
- John R. Rudolph
- Eli Lilly and Company
- Lilly Corporate Center
- www.lilly.com
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io